On behalf of the families who participated at the III Gliomatosis Cerebri Congress, we are pleased to announce a Request for Applications (RFA) to support international research focused on pediatric gliomatosis cerebri.
As a result of COVID-19 around the world, the application deadline has been postponed until October 15, 2020. They will be closely following the evolution of these circumstances, modifying the aforementioned date if necessary to ensure that all applicants have equal opportunities.
Understanding the molecular biology of gliomatosis cerebri will require coordinated use of precious resources, and state-of-the-art technology. One such technology is single-cell RNA-sequencing, which allows for RNA analysis of individual tumor cells separately, resulting in higher resolution and more precise understanding of the tumor ecosystem. Sequencing efforts for gliomatosis cerebri will be led by the Filbin lab at Dana Farber Cancer Institute, in collaboration with Dr Chris Jones' Glioma Team at the Institute of Cancer Research in London and Mara Vinci's team at Bambino Gesu Ospedale Pediatrico in Rome.
III Gliomatosis Cerebri Congress, Barcelona, Spain, 2019
Barcelona hosted the III International Congress on Gliomatosis Cerebri on Sept. 22 and 23, 2019. The congress was organized by the Spanish association Izas, la princesa guisante, co-organized by the French association Franck, un rayon de soleil, and financially supported by associations of families from other European and American countries.
Physicians and scientists from prestigious research centers around the world met and agreed a centralized, coordinated effort was necessary to pool resources, accelerate scientific discovery, and drive patient centered research. From this meeting, the International GC Platform was created.
II Gliomatosis Cerebri Congress
Washington D.C., 2017
Highlights from the first Gliomatosis Cerebri Congress, Curie Institute, Paris, France, 2015